Resources
The AMA has collected more than 400 educational and other resources to provide evidence-based recommendations for physicians and policymakers.
The AMA has collected more than 400 educational and other resources to provide evidence-based recommendations for physicians and policymakers.
The American Academy of Addiction Psychiatry and PCSS-MOUD are excited to offer an updated 2022 Performance-In-Practice activity to help you and your practice treat opioid use disorder. The PIP has been revised to provide up-to-date information and guidance, and now offers an optional 25-question Self-Assessment Exam.
PCSS-MOUD clinical experts, led by Roger Chou, MD, FACP and Melissa Weimer, DO, MCR, FASAM, with Drs. Kevin Sevarino and Frances Levin, have developed a comprehensive core curriculum for healthcare providers in treating chronic pain and addressing concerns about opioid use disorder. The modules in this updated curriculum have been revised by Drs. Chou, Weimer and Sevarino from material released in 2017. The revision includes up-to-date content, including accommodations for shifts in language and terminology.
PCSS-MOUD clinical experts Michelle Lofwall, MD, Larissa Mooney, MD, and Kenneth Morford, MD, who have extensive training and knowledge in addictions, led a team of multidisciplinary professionals in a substantial overhaul of the Substance Use Disorder 101 Core Curriculum for Healthcare Professionals. With the addition of two new module topics, the 23 modules in this 2023 curriculum provide an overview of evidence-based practices in the prevention, identification, and treatment of substance use disorders and co-occurring medical and psychiatric conditions for a variety of populations. Healthcare professionals who complete this curriculum should see an increase in their competence and confidence as they treat patients who are diagnosed with a substance use disorder.
With the passing of the MATE Act, all clinicians applying for their initial DEA registration or seeking renewal are required to complete 8 hours of accredited training in the treatment and management of patients with opioid or other substance use disorders (SUD). This 8-hour MOUD course satisfies that requirement. It is intended for practitioners with limited SUD training who seek an overview of foundational topics.
At the conclusion of this activity, learners should be able to: Review addiction identification and evidence-based treatments. Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients. Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient. Explain the process of buprenorphine induction as well as stabilization and maintenance. Discuss other approved antagonist and agonist medications to treat OUD. Discuss basic office protocols including medical record documentation and confidentially. Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD. Apply for a MAT Waiver Training Certificate to begin treating patients with OUD.
Videos created with patients, family members and medical professionals.
The AMA Substance Use and Pain Care Task Force urges physicians and other health care professions to continue taking action to help reverse the nation’s drug overdose epidemic—and the Task Force also calls on policymakers to take specific steps to remove barriers to evidence-based care for patients with pain and those with a substance use disorder.
Learn More Join the AMA today and help us lead the effort
to reverse the nation’s opioid epidemic.